Journal
HEADACHE
Volume 40, Issue 8, Pages 657-661Publisher
WILEY
DOI: 10.1046/j.1526-4610.2000.040008657.x
Keywords
migraine; cognitive efficiency; sumatriptan; neuropsychological test
Categories
Ask authors/readers for more resources
Background and Objectives.-The measurement of cognitive efficiency during migraine has produced conflicting results primarily due to the types of tests used, The objectives of this pilot study were two-fold: to measure cognitive efficiency during migraine, compared to a migraine-free period, and to evaluate the effects of therapy with a 5-HT1 agonist (sumatriptan injection, 6 mg) on the cognitive efficiency of migraineurs during a migraine, Method.-The Headache Care Center-Automated Neuropsychological Assessment Metrics was administered to 10 migraineurs, three times without a migraine, once during a migraine, and three times after administration of sumatriptan injection (6 mg), Results.-The results demonstrated a significant drop in cognitive efficiency during migraine and recovery 15 minutes after therapeutic injection. Conclusions.-This pilot study is the first to document a significant drop in cognitive functioning during migraine and recovery after administration of a migraine-specific medication.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available